Ro to launch new weight management service
Ro will now be offering a new weight management product, Plenity, through its platform, the direct-to-consumer telehealth company exclusively told MobiHealthNews.
Related Articles
A preventative approach to neurodegenerative diseases
Amprion CEO Russ Lebovitz says proteins in the brain can misfold and form particles that spread from cell to cell, triggering neurodegenerative diseases. A test…
Exclusive: Wolters Kluwer Health announces expanded partnership with
The partnership allows UpToDate Enterprise customers and their patients direct access to a library of multilingual patient education materials within Epic’s EHR and MyChart.
HIMSS submits AI recommendations for safety and innovation
Jonathan French, HIMSS’ senior director of public policy, lays out the key points of HIMSS’ response to the White House’s request for information from the…
HeartBeam, AccurKardia partner to speed up cardiac diagnosis
The alliance will combine HeartBeam’s ECG device with AccurKardia’s monitoring software.
HeartBeam, AccurKardia partner to speed up cardiac diagnosis
The alliance will combine HeartBeam’s ECG device with AccurKardia’s monitoring software.
Eli Lilly sues four telehealth companies for selling copycat drugs
Lilly accuses four compounders of selling unauthorized versions of the pharma giant’s diabetes and weight-loss drugs.
Woebot Health is shutting down its app
The digital mental health tool maker will retire its teen-focused app as of June 30.
Reducing multitasking nurses’ workloads with ambient listening
According to Darren Batara, nursing innovation and informatics manager at Stanford Healthcare, ambient listening can help nurses balance documentation and patient care amid constant interruptions.
User-friendly digital tools can drive patient engagement
Dan Shields, CEO of digital medicine at Ochsner Health, says the health system has succeeded in engaging populations often considered resistant to technology by providing…
Eli Lilly sues four telehealth companies for selling copyright drugs
Lilly accuses four compounders of selling unauthorized versions of the pharma giant’s diabetes and weight-loss drugs.